FDA Adverse Event Injury Summary report: N

GMK SPHERE TOTAL KNEE SYSTEM

MDR report key: 23436205 · Received October 31, 2025

Report

Report Number
3005180920-2025-01048
Event Type
Injury
Date Received
October 31, 2025
Date of Event
October 8, 2025
Report Date
October 31, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630971262003
PMA / PMN Number
K202022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEWS PERFORMED ON 14 OCTOBER 2025: GMK-SPHERE 02.12.E0510FR GMK-SPHERE TIBIAL INSERT E-CROSS - FLEX 5R - 10MM (K202022) LOT 2310265: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 02-JUN-2023. EXPIRATION DATE: 2028-05-21. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL THE ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. GMK-SPHERE 02.15.E035 MOTO PATELLA E-CROSS Ø35 (K213071) LOT 2238173: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 10-NOV-2022. EXPIRATION DATE: 2027-10-27. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. CONCLUSIONS: THE SURGEON REVISED LINER AND REMOVED SOME OSTEOPHYTES, TO RESTORE THE JOINT FROM FLEXION CONTRACTURE, STIFNESS. THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT.

Description of Event or Problem · 0

THE PATIENT HAD PAIN AND CAUSE IS UNKNOWN. THE SURGEON DETERMINED THE PATIENT HAD A SLIGHT FLEXION CONTRACTURE. AT ABOUT 1 YEAR AND 11 MONTHS POST PRIMARY THE SURGEON UPSIZED THE POLY, REVISED THE LINER FROM A 10MM TO AN 11MM WHILE REMOVING POSTERIOR OSTEOPHYTES. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1562080 GMK SPHERE TOTAL KNEE SYSTEM GMK-SPHERE TIBIAL INSERT E-CROSS - FLEX 5R - 10MM JWH MEDACTA INTERNATIONAL SA 02.12.E0510FR 2310265 07630971262003

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention